English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Predictors of neuropsychiatric side effects and therapy response of dopamine agonist therapy in patients with prolactinomas: a clinical study concept

MPS-Authors
/persons/resource/persons124315

Athanasoulia,  A.
AG Stalla, Günter, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80528

Sievers,  C.
AG Stalla, Günter, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80379

Ising,  M.
AG Ising, Marcus, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80563

Uhr,  M.
AG Uhr, Manfred, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

Stalla,  G. K.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Athanasoulia, A., Sievers, C., Ising, M., Uhr, M., & Stalla, G. K. (2009). Predictors of neuropsychiatric side effects and therapy response of dopamine agonist therapy in patients with prolactinomas: a clinical study concept. Experimental and Clinical Endocrinology & Diabetes, 117(10), 660-660.


Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-9170-3
Abstract
There is no abstract available